Related Experiment Video
Updated: May 4, 2026

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics
Published on: March 26, 2018
GAP-independent functions of DLC1 in metastasis
David Barras1, Christian Widmann
1Department of Physiology, University of Lausanne, Bugnon 7, 1005, Lausanne, Switzerland.
Abstract:
Metastases are responsible for most cancer-related deaths. One of the hallmarks of metastatic cells is increased motility and migration through extracellular matrixes. These processes rely on specific small GTPases, in particular those of the Rho family. Deleted in liver cancer-1 (DLC1) is a tumor suppressor that bears a RhoGAP activity. This protein is lost in most cancers, allowing malignant cells to proliferate and disseminate in a Rho-dependent manner. However, DLC1 is also a scaffold protein involved in alternative pathways leading to tumor and metastasis suppressor activities. Recently, substantial information has been gathered on these mechanisms and this review is aiming at describing the potential and known alternative GAP-independent mechanisms allowing DLC1 to impair migration, invasion, and metastasis formation.
Insights
Deleted in liver cancer-1 (DLC1) protein loss promotes cancer metastasis. This review explores DLC1
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Metastases cause most cancer deaths, driven by increased cancer cell motility and migration.
- Rho family GTPases regulate cell migration, and their dysregulation is common in cancer.
- Deleted in liver cancer-1 (DLC1) is a tumor suppressor with RhoGAP activity, often lost in cancers, promoting Rho-dependent malignant cell dissemination.
Purpose of the Study:
- To review the known and potential GAP-independent mechanisms of DLC1 tumor and metastasis suppression.
- To elucidate alternative pathways through which DLC1 inhibits cancer cell migration, invasion, and metastasis formation.
Main Methods:
- Literature review of studies on DLC1 function beyond its RhoGAP activity.
- Analysis of research on DLC1's role as a scaffold protein in cancer progression.
- Synthesis of information on DLC1's impact on cell migration, invasion, and metastasis.
Main Results:
- DLC1 acts as a scaffold protein, engaging in alternative pathways that suppress tumor and metastasis formation.
- These GAP-independent mechanisms contribute to inhibiting cancer cell migration and invasion.
- Loss of DLC1 function, beyond its RhoGAP activity, facilitates cancer dissemination.
Conclusions:
- DLC1 possesses critical tumor and metastasis suppressor functions independent of its RhoGAP activity.
- Understanding these alternative mechanisms is crucial for developing novel anti-metastasis therapies.
- Targeting DLC1's scaffold functions could offer new strategies to combat cancer metastasis.
More Related Videos
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Cell Migration through Invadopodia

